Company intelligence / Profile preview

Segue

New Orleans, Louisiana, USA

Ownership: Private
Development stage: Other

Overview

Segue Therapeutics is a biotechnology company focused on discovering and developing novel therapies for fibrotic diseases. The company utilizes a proprietary drug discovery platform to identify small molecules that inhibit the conversion of fibroblasts into myofibroblasts, a key driver of tissue scarring. Their lead programs target systemic sclerosis (scleroderma) and other organ-specific fibroses. By repurposing and optimizing existing chemical scaffolds, Segue aims to accelerate the delivery of effective treatments to patients with limited options.

Therapeutic areas: NephrologyPulmonologyRheumatologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Segue.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Segue.

Explore the full profile